1. Zonnenberg I., De Waal K. The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review. Acta Paediatr. 2012. Vol. 101, N 3. P. 247-251.

2. Kirklin J.W., Barratt-Boyes B.G. Patent ductus arteriosus. In: Kirklin J.W., Barratt-Boyes B.G. (eds). Cardiac Surgery. Fourth edition, 2013, pp 1342-1355.

3. Semberova J. et al. Spontaneous Closure of Patent Ductus Arteriosus in Infants 1500 g Artic. Pediatr. 2017. Vol. 140, N 2. e: 20164258.

4. Momma K., Monma M., Toyoshima K. et al. Etiology and Morphogenesis of Congenital Heart Disease: From Gene Function and Cellular Interaction to Morphology. Springer; Tokyo, Japan: 2016. pp. 263-265.

5. Lin T.Y., Yeh J.L., Hsu J.H. Role of Extracellular Matrix in Pathophysiology of Patent Ductus Arteriosus: Emphasis on Vascular Remodeling. Int J Mol Sci. 2020 Jul 4; 21(13):4761.

6. Hermes-DeSantis E.R., Clyman R.I. Patent ductus arteriosus: Pathophysiology and management. J. Perinatol. 2006; 26(Suppl. 1): S14-S18.

7. Shelton E.L., Singh G.K., Nichols C.G. Novel drug targets for ductus arteriosus manipulation: Looking beyond prostaglandins. Semin. Perinatol. 2018; 42:221-227. doi: 10.1053/j.semperi.2018.05.004.

8. Clyman R.I., Heymann M.A. Pharmacology of the ductus arteriosus. Pediatr Clin North Am 1981; 28:77.

9. Yokoyama U., Minamisawa S., Ishikawa Y. Regulation of vascular tone and remodeling of the ductus arteriosus. J. Smooth Muscle Res. 2010; 46:77-87. doi: 10.1540/jsmr.46.77.

10. Koch J. et al. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics. 2006. Vol. 117, N 4. P. 1113-1121.

11. Lee J.A. et al. Perinatal risk factors of symptomatic preterm patent ductus arteriosus and secondary ligation. Pediatr. Neonatol. Elsevier Taiwan LLC, 2020. Vol. 61, N 4. P. 439-446.

12. Gonzalez A. et al. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J. Pediatr. 1996. Vol. 128, N 4. P. 470-478.

13. Simon S.R. et al. E-Mail Systematic Review and Meta-Analysis Platelet Counts and Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis. Neonatology. 2015. Vol. 108, N 2. P. 143-151.

14. Артюх Л.Ю., Карелина Н.Р., Оппедизано М.Д.Л., и др. Современный взгляд на классификацию и диагностику открытого артериального протока (обзор) // Российские биомедицинские исследования. 2023. Т. 8. N 2. С. 78-91.

15. Зиньковский М.Ф. Врожденные пороки сердца. Открытый артериальный (боталлов) проток. К.: Книга плюс; 2008. С. 310-319.

16. Прийма Н.Ф., Попов В.В., Иванов Д.О. Эхокардиографическое исследование в дифференциальной диагностике открытого артериального протока у детей. Педиатр. 2016; 7(4): 119-27. DOI: 10.17816/PED74119-127.

17. Kouchoukos N.T., Blackstone E.H., Hanley F.L., Kirklin J.K. Kirklin/Barratt-Boyes cardiac surgery: morphology, diagnostic criteria, natural history, techniques, results, and indications. 4^th ed. Philadelphia: Elsevier; 2013.

18. Urquhart DS N.R. How good is clinical examination at detecting a significant patent ductus arteriosus in the preterm neonate? Arch Dis Child. 2003. Vol. 88, N 1. P. 85-86.

19. Ефремов С.О., Туманян М.Р., Андерсон А.Г. Открытый артериальный проток у недоношенных новорожденных: патофизиологические особенности и современные подходы к диагностике и лечению. Детские болезни сердца и сосудов. 2005; N 1; стр. 8 - 17.

20. Gillam-Krakauer M., Reese J. Diagnosis and management of patent ductus arteriosus. Neoreviews. 2018. Vol. 19, N 7. P. e394-e402.

21. Polglase G.R. et al. Circulatory insufficiency and Hypotension Related to the Ductus Arteriosus in Neonates. Front Pediatr. 2018. Vol. 6. P. 62.

22. Bell EF, Warburton D, Stonestreet BS, Oh W. Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants. N Engl J Med 1980; 302:598.

23. Rowe RD, Lowe JB. Auscultation in the diagnosis of persistent ductus arteriosus in infancy: a study of 50 patients. N Z Med J 1964; 63:195.

24. Conrad C., Newberry D. Understanding the Pathophysiology, Implications, and Treatment Options of Patent Ductus Arteriosus in the Neonatal Population. Adv. Neonatal Care. Lippincott Williams and Wilkins, 2019. Vol. 19, N 3. P. 179-187.

25. Clyman R.I. et al. PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age. J. Pediatr. 2019. Vol. 205. P. 41-48. e6.

26. Park J.S. et al. Risk factors and effects of severe late-onset hyponatremia on long-term growth of prematurely born infants. Pediatr. Gastroenterol. Hepatol. Nutr. 2020. Vol. 23, N 5. P. 472-483.

27. Seo E.S. et al. Changes in serum creatinine levels and natural evolution of acute kidney injury with conservative management of hemodynamically significant patent ductus arteriosus in extremely preterm infants at 23-26 weeks of gestation. J. Clin. Med. 2020. Vol. 9, N 3. P. 17-21.

28. Writing Committee Members; Isselbacher E.M., Preventza O., Hamilton Black Iii J. et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022 Dec 13; 80(24):e223-e393. doi: 10.1016/j.jacc.2022.08.004.

29. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 23: e143-263.

30. Singh Y. et al. International evidence-based guidelines on Point of Care Ultrasound (POCUS) for critically ill neonates and children issued by the POCUS Working Group of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC). Crit Care. 2020. Vol. 24, N 1. P. 65.

31. Gillam-Krakauer M., Reese J. Diagnosis and management of patent ductus arteriosus. Neoreviews. American Academy of Pediatrics, 2018. Vol. 19, N 7. P. e394-e402.

32. Бокерия Л.А., Шаталов К.В. Детская кардиохирургия. 2016. Изд. НМИЦ ССХ им. А.Н. Бакулева.

33. Коков А.Н., Семенов С.Е., Масенко В.Л. и др. Мультиспиральная компьютерная томография в диагностике врожденных пороков сердца у детей первых лет жизни. Комплексные проблемы сердечно-сосудистых заболеваний. 2013; 4: 42-9.

34. Allen H.D., Driscoll D.J., Shaddy R.E., Feltes T.F. In. Moss & Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult. V.2. Lippincott Williams & Wilkins; 2013.

35. Mavroudis C., Backer C.L. Pediatric cardiac surgery, 4th ed, 2013, 256-282.

36. Jaleel M.A., Rosenfeld C.R. Patent ductus arteriosus and intraventricular hemorrhage: A complex association. J. Pediatr. 2013. Vol. 163, N 1. P. 8-10.

37. Nagata H. et al. Left ventricular efficiency after ligation of patent ductus arteriosus for premature infants // J. Thorac. Cardiovasc. Surg. Elsevier Inc., 2013. Vol. 146, N 6. P.1353-1358.

38. Khalil M., Jux C., Rueblinger L., Behrje J., Esmaeili A., Schranz D. Acute therapy оf newborns with critical congenital heart disease. Transl Pediatr. 2019 Apr; 8(2):114-126.

39. Kantor P.F., Lougheed J., Dancea A., McGillion M., Barbosa N., Chan C., et al. Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines. Can J Cardiol. 2013 Dec; 29(12):1535-52.

40. Masarone D., Valente F., Rubino M., Vastarella R., Gravino R., Rea A., et al. Pediatric Heart Failure: A Practical Guide to Diagnosis and Management. Pediatr Neonatol. 2017 Aug; 58(4):303-312.

41. Feltes T.F., Bacha E., Beekman R.H. 3rd, et al. American Heart Association Congenital Cardiac Defects Committee of the Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Cardiovascular Radiology and Intervention. Indications for cardiac catheterization and interventions for cardiac catheterization and intervention in pediatric cardiac disease; a scientific statement from the American Heart Association. Circulation 2011; 123:2607-52.

42. Ohlsson A S.S. Cochrane Database of Systematic Reviews Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants (Review). Cochrane Database. 2018. Vol. 9, N 9. P. 003481.

43. Marconi E. et al. Efficacy and safety of pharmacological treatments for patent ductus arteriosus closure: A systematic review and network meta-analysis of clinical trials and observational studies. Pharmacol. Res. Elsevier, 2019. Vol. 148, N August. P. 104418.

44. Jansen E.J.S. et al. Factors Associated With Benefit of Treatment of Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis // Front. Pediatr. 2021. Vol. 9, N February. P. 1-12.

45. Celermajer D.S., Sholler G.F., Hughes C.F., Baird D.K. Persistent ductus arteriosus in adults. A review of surgical experience with 25 patients. Med J Aust. 1991; 155:233-6.

46. Fripp RR, Whitman V, Waldhausen JA, Boal DK. Ductus arteriosus aneurysm presenting as pulmonary artery obstruction: diagnosis and management. J Am Coll Cardiol 1985; 6:234.

47. Callegari A., Burkhardt B., Relly C. et al. Ductus arteriosus-associated infective endarteritis: Lessons from the past, future perspective. Congenit Heart Dis. 2019 Jul; 14(4):671-677. doi: 10.1111/chd.12830.

48. Weisz D.E., Giesinger R.E. Surgical management of a patent ductus arteriosus: Is this still an option? Seminars in Fetal and Neonatal Medicine. W.B. Saunders Ltd, 2018. Vol. 23, N 4. P. 255-266.

49. Weisz D.E. et al. PDA li ation and health outcomes: A meta-analysis. Pediatrics. American Academy of Pediatrics, 2014. Vol. 133, N 4.

50. Park J. et al. Patent ductus arteriosus treatment trends and associated morbidities in neonates. Sci. Reports. 2021. Vol. 11, N 1. P. 10689.

51. Разумовский А.Ю., Алхасов А.Б., Митупов З.Б., Феоктистова Е.В., Ситникова М.И., Коллеров М.Ю. Хирургическая коррекция открытого артериального протока у детей. Российский вестник детской хирургии, анестезиологии и реаниматологии. 2017. P. 25-33.

52. Cetta F, Deleon SY, Roughneen PT, Graham LC, Lichtenberg RC, Bell TJ, et al. Cost-effectiveness of transaxillary muscle-sparing same-day operative closure of patent ductus arteriosus. Am J Cardiol 1997; 79:1281.

53. Monteiro A.J., Canale L.S., Rosa R.V. et al. Minimally invasive thoracotomy (muscle-sparing thoracotomy) for occlusion of ligamentum arteriosum (ductus arteriosus) in preterm infants. Rev Cir Cardiovasc. 2007; 22(3):285-290. doi: 10.1590/S0102-76382007000300003.

54. Chen H., Weng G., Chen Z. et al. Comparison of posterolateral thoracotomy and video-assisted thoracoscopic clipping for the treatment of patent ductus arteriosus in neonates and infants. Pediatr Cardiol. 2011; 32:386-390. doi: 10.1007/s00246-010-9863-x.

55. Kalman A., Verebely T. The use of axillary skin crease incision for thoracotomies of neonates and children. Eur J Pediatr Surg. 2002; 12:226-229. doi: 10.1055/s-2002-34487.

56. Taguchi T., Nagata K., Kinoshita Y. et al. The utility of muscle sparing axillar skin crease incision for pediatric thoracic surgery. Pediatr Surg Int. 2012; 28:239-244. doi: 10.1007/s00383-011-3013-2.

57. Coster DD, Gorton ME, Grooters RK, Thieman KC, Schneider RF, Soltanzadeh H. Surgical closure of the patent ductus arteriosus in the neonatal intensive care unit. Ann Thorac Surg 1989; 48:386.

58. Eggert LD, Jung AL, McGough EC, Ruttenberg HD. Surgical treatment of patent ductus arteriosus in preterm infants. Four-year experience with ligation in the newborn intensive care unit. Pediatr Cardiol 1982; 2:15.

59. Kron IL, Mentzer RM Jr, Rheuban KS, Nolan SP. A simple, rapid technique for operative closure of patent ductus arteriosus in the premature infant. Ann Thorac Surg 1984; 37:422.

60. Eilers L., Qureshi A.M. Advances in Pediatric Ductal Intervention: an Open or Shut Case? Curr Cardiol Rep. 2020 Jan 29; 22(3):14.

61. Benitz W.E. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 2010; 30:241-252.

62. Noori S. Patent ductus arteriosus in the preterm infant: to treat or not to treat? J Perinatol 2010; 30:S31-S37.

63. Goncalves-Estella A, Perez-Villoria J, Gonzalez-Reoyo F, Gimenez-Mendez JP, Castro-Cels A, Castro-Llorens M. Closure of a complicated ductus arteriosus through the transpulmonary route using hypothermia. J Thorac Cardiovasc Surg 1975; 69:698.

64. Orimoto Y., Ishibashi H., Sugimoto I. et al. A case of patent ductus arteriosus in an elderly patient treated by thoracic endovascular aortic repair. Ann Vasc Dis 2016; 9:326-9.

65. Muller C.O., Ali L., Matta R. et al. Thoracoscopy Versus Open Surgery for Persistent Ductus Arteriosus and Vascular Ring Anomaly in Neonates and Infants. J Laparoendosc Adv Surg Tech A. 2018 Aug; 28(8):1008-1011. doi: 10.1089/lap.2017.0340

66. Burke RP, Wernovsky G, van der Velde M, Hansen D, Castaneda AR. Video-assisted thoracoscopic surgery for congenital heart disease. J Thorac Cardiovasc Surg 1995; 109:499.

67. Slater B.J., Rothenberg S.S. Thoracoscopic Management of Patent Ductus Arteriosus and Vascular Rings in Infants and Children. J Laparoendosc Adv Surg Tech A. 2016 Jan; 26(1):66-9.

68. Nezafati M.H., Soltani G., Mottaghi H. et al. Video-assisted thoracoscopic patent ductus arteriosus closure in 2,000 patients. Asian Cardiovasc Thorac Ann 2011; 19:393-398.

69. Vanamo K, Berg E, Kokki H, Tikanoja T. Video-assisted thoracoscopic versus open surgery for persistent ductus arteriosus. J Pediatr Surg 2006; 41:1226-9.

70. Dutta S., Mihailovic A., Benson L., Kantor PF, Fitzgerald PG, Walton JM, et al. Thoracoscopic ligation versus coil occlusion for patent ductus arteriosus: a matched cohort study of outcomes and cost. Surg Endosc 2008; 22:1643-8.

71. Masura J, Walsh KP, Thanopoulous B, Chan C, Bass J, Goussous Y, et al. Catheter closure of moderate- to large-sized patent ductus arteriosus using the new Amplatzer duct occluder: immediate and short-term results. J Am Coll Cardiol 1998; 31:878.

72. Wang G., Wu Y., Pan Z. et al. Transesophageal echocardiography-guided percutaneous patent ductus arteriosus closure without fluoroscopy. J Cardiothorac Surg. 2023 Apr 15; 18(1):142.

73. Rosenthal E., Qureshi SA, Reidy J., Baker EJ, Tynan M. Evolving use of embolisation coils for occlusion of the arterial duct. Heart 1996; 76:525.

74. Fortescue E.B., Lock J.E., Galvin T., McElhinney D.B. To close or not to close: the very small patent ductus arteriosus. Congenit Heart Dis 2010; 5:354-65.

75. Fedderly RT, Beekman RH 3rd, Mosca RS, Bove EL, Lloyd TR. Comparison of hospital charges for closure of patent ductus arteriosus by surgery and by transcatheter coil occlusion. Am J Cardiol 1996; 77:776.

76. Scerbo D. et al. Percutaneous Closure of the Patent Ductus Arteriosus in Very-Low-Weight Infants Practice Gaps. Neoreviews. 2020. Vol. 21, N 7. P. 469-478.

77. Agrawal H. et al. New Patent Ductus Arteriosus Closure Devices and Techniques. Interventional Cardiology Clinics. Elsevier Inc., 2019. Vol. 8, N 1. P. 23-32.

78. Narayan S.A. et al. Long-term follow-up is not indicated after routine interventional closure of persistent arterial ducts. Catheter. Cardiovasc. Interv. John Wiley and Sons Inc., 2015. Vol. 86, N 1. P. 100-104.

79. Abadir S., Boudjemline Y., Rey C., Petit J., Sassolas F., Acar P., et al. Significant persistent ductus arteriosus in infants less or equal to 6 kg: percutaneous closure or surgery? Arch Cardiovasc Dis 2009; 102:533-540.

80. Nunez F.R., Alvarez A.A., Trisac J.L., Pardeiro C.A. Percutaneous closure of patent ductus arteriosus in preterm infants. Rev Esp Cardiol 2010; 63:740-41.

81. Prsa M., Ewert P. Transcatheter closure of a patent ductus arteriosus in a preterm infant with an Amplatzer vascular plug IV device. Catheter Cardiovasc Interv 2011; 77:108-111.

82. Рентгенэндоваскулярная хирургия. Национальное Руководство. В 4 т. Т. 1. Врожденные пороки сердца. Под ред. Б.Г. Алекяна. М., "Литтерра", 2017.

83. Харламова Н.В., Спивак Е.М., Фисюк Ю.А., Климачев А.М. Открытый артериальный проток у глубоконедоношенных детей. Ярославль: Филигрань, 2021.

84. Ngo S., Profit J., Gould J.B. Trends in Patent Ductus Arteriosus Diagnosis and Management for Very Low Birth Weight Infants. Pediatrics. 2017. Vol. 139, N 4. P. 20162390.

85. Malviya M., Ohlsson A., Shah S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2008. N 1. P. 003951.

86. Bilkis A.A., Alwi M., Hasri S. et al. The Amplatzer duct occluder: experience in 209 patients. J. Am. Coll. Cardiol. 2001; 37: 258-61.

87. Faella H.J., Hijazi Z.M. Closure of the patent ductus arteriosus with the Amplatzer PDA device: immediate results of the international clinical trial.Catheter Cardiovasc.Interv. 2000; 51: 50-4.

88. Podnar T., Gavora P., Masura J. Percutaneous closure of patent ductus arteriosus: complementary use of detachable Cook patent ductus arteriosus coils and Amplatzerductoccluders. Eur. J. Pediatr. 2000; 159: 293-6.

89. Шарыкин А.С. Врожденные пороки сердца. Москва. 2005.

90. Nguyen L., Cook S.C. Coarctation of the Aorta: Strategies for Improving Outcomes. Cardiol Clin 2015 Nov; 33:521-30, vii.

91. Подзолков В.П., Кассирский Г.И. (ред.). Реабилитация больных после хирургического лечения врожденных пороков сердца. М.: НЦССХ им. А.Н. Бакулева; 2015.

92. Yang M., Chang Y.S., Ahn S.Y. et al. Conservative Management of Patent Ductus Arteriosus Is Feasible in the Peri-Viable Infants at 22-25 Gestational Weeks. Biomedicines. 2022 Dec 28; 11(1):78.

93. Saxena A., Relan J., Agarwal R., Awasthy N., Azad S., Chakrabarty M. et all. Indian guidelines for indications and timing of intervention for common congenital heart diseases: Revised and updated consensus statement of the Working group on management of congenital heart diseases. Ann Pediatr Cardiol. 2019 Sep-Dec; 12(3):254-286.

94. DaCruz E.M., Ivy D., Jaggers J. Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care. London, Springer London, 2014. DOI: 10.1007/978-1-4471-4619-3.

95. Riambau V., B ckler D., Brunkwall J., Cao P., Chiesa R., et al. Editor"s Choice - Management of Descending Thoracic Aorta Diseases: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2017 Jan; 53(1):4-52.

96. Silversides C.K., Kiess M., Beauchesne L., Bradley T., Connelly M., et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan"s syndrome. Can J Cardiol 2010; 26: e80-e97.

97. Фальковский Г.Э., Крупянко С.М. Сердце ребенка: книга для родителей о врожденных пороках сердца. - М.: Никея, 2011.

98. Kemmochi M., Senzaki H., Miyaji K., Hashimoto M., Yamaguchi A., Ooka M., Yokozeki Y., Ishii M. Optimal timing of video-assisted thoracoscopic surgery for patent ductus arteriosus in preterm infants born at <= 28 weeks of gestation. Pediatr Int. 2019 Aug; 61(8):792-796.

99. Reybrouck T., Gewillig M., Budts W., Buys R. (2017) Exercise Tolerance in Children with Simple Congenitally Corrected Transposition of the Great Arteries: A Comparative Study. J Nov Physiother Phys Rehabil 4(3): 066-070.

100. Физическая и реабилитационная медицина. Национальное руководство. Краткое издание // Под ред. Г.Н. Пономаренко. М.: ГЭОТАР-Медиа, 2017. - 512 с. / Глава 21. Хан М.А., Куянцева Л.В. Заболевания сердечно-сосудистой системы. - С. 447-452.

101. Bjarnason-Wehrens B. et al. Cardiac rehabilitation in congenital heart disease //Cardiovascular Prevention and Rehabilitation. - Springer, London, 2007. - С. 361-375.

102. Tikkanen A.U. et al. Paediatric cardiac rehabilitation in congenital heart disease: a systematic review //Cardiology in the young. - 2012. - Т. 22. - N. 3. - С. 241-250.

103. Lai W.W., Mertens L.L., Cohen M.S., Geva T. Echocardiography in pediatric and congenital heart disease. From Fetus to Adult. Second Edition. Wiley Blackwell; 2016.

104. Siassi B., Noori Sh., Wong P., Acherman R.M.-H.E. Practical Neonatal Echocardiography. 1th ed. Mc Graw Hill Education, 2019.

105. Cox K., Algaze-Yojay C., Punn R., Silverman N. The Natural and Unnatural History of Ventricular Septal Defects Presenting in Infancy: An Echocardiography-Based Review. J Am Soc Echocardiogr. 2020 Jun; 33(6):763-770.

106. Cantinotti M., Giordano R., Scalese M., Murzi B., Assanta N., Spadoni I. et al. Nomograms for two-dimensional echocardiography derived valvular and arterial dimensions in Caucasian children. Journal of Cardiology 69 (2017) 208-215.

107. Sumitomo N.F., Kodo K., Maeda J., Miura М., Yamagishi H. Echocardiographic Left Ventricular Z-Score Utility in Predicting Pulmonary-Systemic Flow Ratio in Children With Ventricular Septal Defect or Patent Ductus Arteriosus Circulation Journal Circ J 2022; 86: 128-135.

108. Разумовский А.Ю. Гемодинамически значимый артериальный проток у недоношенного новорожденного, Общероссийская общественная организация содействия развитию неонатологии "Российское общество неонатологов" (РОН), Общественная организация "Российская ассоциация специалистов перинатальной медицины" (РАСПМ) / А.Ю. Разумовский, Д.Н. Дягтерев, Р.Р. Мовсесян [и др.]. - М.: Министерство здравоохранения РФ, 2020. - С. 83.

109. Van Laere D., van Overmeire B., Gupta S. et al. Application of NPE in the assessment of a netent ductus arteriosus. Pediatric Res. 2018; 84: S46-56.

110. Mezu-Ndubuisi O.J., Agarwal G., Raghavan A. et al. Patent Ductus Arteriosus in Premature Neonates. Drugs. 2012; 72: 907-16.

111. Прийма Н.Ф., Попов В.В., Иванов Д.О. Эхокардиографическое исследование в дифференциальной диагностике открытого артериального протока у детей. Педиатр (Санкт-Петербург). 2016; 7(4):119-127.

112. Элисдэйр Райдинг. Эхокардиография. Практическое руководство: пер. с англ. - М.: Медпрессинформ, 2010. - С. 157-162. [Elisdeyr Rayding]. Echocardiography. Moscow: Medpress-inform; 2010. P. 157-162. (In Russ.)].

113. Clyman R.I. Patent ductus arteriosus, its treatments, and the risks of pulmonary morbidity. Semin. Perinatol. 2018; 42:235-242.

114. Abu-Shaweesh J.M., Almidani E. PDA: Does it matter? Int. J. Pediatr. Adolesc. Med. 2020; 7:9-12.

115. Nawaytou H., Hills N.K., Clyman R.I. Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension. Pediatr Res. 2023; 94(2):547-554.

116. Gentle S.J., Travers C.P., Clark M. et al. Patent ductus arteriosus and development of bronchopulmonary dysplasia-associated pulmonary hypertension. Am J Respir Crit Care Med. 2023; 207(7):921-928.

117. Lin C., Liu L., Liu Y., Leng J. Recent developments in next-generation occlusion devices. Acta Biomater. 2021 Jul 1; 128:100-119. doi: 10.1016/j.actbio.2021.04.050.

118. Sheikh A.M., Duke A.K., Sattar H. Transcatheter closure of Patent Ductus Arteriosus through only venous route. J Pak Med Assoc. 2018 Mar; 68(3):469-470.

119. Козлов Ю.А., Новожилов В.А., Ежова И.В. и др. Торакотомия и торакоскопия в лечении открытого артериального протока у детей с массой тела менее 2500 гр. Хирургия (Москва). 2014; (1):64-72. PMID: 24429718.

120. Приказ Минздрава РФ от 20 октября 2020 г. N 1134н "Об утверждении порядка медицинского обследования реципиента, проведения проб на индивидуальную совместимость, включая биологическую пробу, при трансфузии донорской крови и (или) ее компонентов"

121. Аксельрод Б.А., Балашова Е.Н., Баутин А.Е., Баховадинов Б.Б., Бирюкова Л.С. и др. Клиническое использование эритроцитсодержащих компонентов донорской крови. Гематология и трансфузиология. 2018; 63(4):372-435.

122. Национальные рекомендации по ведению детей с врожденными пороками сердца. Ред. Л.А. Бокерия. М., 2014.

123. Постановление Главного государственного санитарного врача РФ от 28 января 2021 г. N 4 "Об утверждении санитарных правил и норм СанПиН 3.3686-21 "Санитарно-эпидемиологические требования по профилактике инфекционных болезней".

124. Monagle P, Chan AKC, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-G ttl U, Vesely SK. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl):e737S-e801S.

125. Купряшов А.А., Токмакова К.А. Нарушения системы свертывания крови в сердечно-сосудистой хирургии. В кн.: Система гемостаза. Теоретические основы и клиническая практика: Национальное руководство / О.А. Рукавицын, С.В. Игнатьев, А.Г. Румянцев [и др.]. Москва: Общество с ограниченной ответственностью Издательская группа "ГЭОТАР-Медиа", 2024. 944 с. ISBN 978-5-9704-8497-5.

126. Mauritz G.J., Rizopoulos D., Groepenhoff H. et al. Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension. Am J Cardiol. 2011. 108(11):1645-50.

127. Roberts E, Ludman AJ, Dworzynski K, Al-Mohammad A, Cowie MR, McMurray JJ, Mant J; NICE Guideline Development Group for Acute Heart Failure. The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting. BMJ. 2015 Mar 4; 350: h910.

128. Zaphiriou A, Robb S, Murray-Thomas T, Mendez G, Fox K, McDonagh T, Hardman SM, Dargie HJ, Cowie MR. The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur J Heart Fail. 2005 Jun; 7(4):537-41.

129. Fuat A, Murphy JJ, Hungin AP, Curry J, Mehrzad AA, Hetherington A, Johnston JI, Smellie WS, Duffy V, Cawley P. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract. 2006 May; 56(526):327-33.

130. Yamamoto K, Burnett JC Jr, Bermudez EA, Jougasaki M, Bailey KR, Redfield MM. Clinical criteria and biochemical markers for the detection of systolic dysfunction. J Card Fail. 2000 Sep; 6(3):194-200.

131. Svobodov A.A., Kupryashov A.A., Dobroserdova T.K., Levchenko E.G., Tumanyan M.R., Anderson A.G. A new approach to the interpretation of B-type natriuretic peptide concentration in children with congenital heart disease. Journal of Laboratory Medicine, 2023; 47(5):225-232.

132. Ungerleider G.D., Williams D.A., Ungerleider R.M. Patent ductus arteriosus. Critical heart disease in infants and children Elsevier 2018. p. 53643.

133. Giglia T., Massicotte M., Tweddell J. et al. Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation. 2013; 128:2622-2703.

134. Potsiurko S, Dobryanskyy D, Sekretar L. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial. BMC Pediatr. 2021 Jun 19; 21(1):286.

135. Khan SS, Sithisarn T, Bada HS, Vranicar M, Westgate PM, Hanna M. Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus. J Perinatol. 2017 Dec; 37(12):1319-1324.

136. Nuntnarumit P., Chongkongkiat P., Khositseth A. N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants. Acta Paediatr. 2011 Sep; 100(9):1217-21.

137. Riccabona M. Neonatal neurosonography. Eur J Radiol. 2014 Sep; 83(9):1495-506.

138. Maller VV, Cohen HL. Neurosonography: Assessing the Premature Infant. Pediatr Radiol. 2017 Aug; 47(9):1031-1045.

139. Mitra S, Florez ID, Tamayo ME, Mbuagbaw L, Vanniyasingam T, Veroniki AA, Zea AM, Zhang Y, Sadeghirad B, Thabane L. Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysis. JAMA. 2018 Mar 27; 319(12):1221-1238.

140. Khanafer-Larocque I, Soraisham A, Stritzke A, Al Awad E, Thomas S, Murthy P, Kamaluddeen M, Scott JN, Mohammad K. Intraventricular Hemorrhage: Risk Factors and Association With Patent Ductus Arteriosus Treatment in Extremely Preterm Neonates. Front Pediatr. 2019 Oct 22; 7:408.